Investment banking

Healthcare

We advise healthcare companies, from medical devices and surgical robotics to digital health and healthcare services.

01
Mergers & acquisitions

Sell-side and buy-side advisory, with strategic and financial acquirers, in France and abroad.
02
LBO & MBO

Advising management teams and shareholders on leveraged and management buyouts.
03
Capital raising

From Series A to late-stage venture, with venture capital, growth equity and strategic investors.

Case studies

Healthcare 2016 – 2026

eCential Robotics: from seed round to Enovis offer

Apparius has advised eCential Robotics (formerly Surgivisio) since its first financing rounds. Built on more than 15 years of research in computer-assisted surgery in Grenoble, the company developed Op.n®, a platform that combines 2D/3D imaging, surgical navigation and active robotics in a single architecture, cleared by the FDA for spine surgery.

We advised the company on its 2016 seed round with MedInnov, its €10.5M Series A in 2018 with Bpifrance and Trail, and its close to €100M financing in 2021, combining equity, quasi-equity and debt, which allowed it to scale up production and prepare its entry into North America.

In September 2026, Enovis (NYSE: ENOV) made a binding offer to acquire eCential Robotics at an upfront enterprise value of €155 million, with up to €35 million in milestone payments. Enovis plans to build a robotics centre of excellence in Grenoble around the team and to launch a next-generation robot, starting with the knee and then the shoulder. Closing is expected in the fourth quarter of 2026.

Exclusive financial advisor to the company

Healthcare 2023

Imactis sold to GE HealthCare

Imactis was a natural fit for the newly independent GE HealthCare, strengthening its capabilities in interventional guidance, particularly in CT-based procedures. The IMACTIS CT-Navigation system, which offers precise needle guidance for complex procedures, helps GE HealthCare improve procedural accuracy, reducing procedure time and radiation exposure.

For Imactis, the compelling argument was GE HealthCare’s ability to scale the technology globally and make it a standard in minimally invasive procedures.

Exclusive financial advisor to the sellers

Healthcare 2018

Orthotaxy acquired by Johnson & Johnson

In 2018, Johnson & Johnson acquired Orthotaxy, a French company developing a next-generation robotic-assisted surgery platform for total and partial knee replacement. The acquisition was a strategic move to integrate Orthotaxy’s technology into a comprehensive orthopaedic platform.

Orthotaxy’s technology went on to become a key component of the VELYS Robotic-Assisted Solution, designed for use with the ATTUNE Total Knee System and part of the broader VELYS Digital Surgery platform.

Exclusive financial advisor to the sellers